CLINICAL_TRIALS
trial_result
· 2013-10-30
Clinical Trial Update: Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults [Phase 2]
Summary
Phase IIa dose-ranging study of GSK1349572 (dolutegravir) in HIV-1 infected adults completed; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED | Results posted: 2013-10-30